Brain Tumor

Oncology·MeSH: Brain Neoplasms

12 drugs in development·6 companies·9 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)

Phase 3(4)

Drug	Company
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 & AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 and AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons A10 and AS2-1	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)

Phase 2(3)

Drug	Company
ad-rts-hil-12	Alaunos Therapeutics, Inc. (TCRT)
oral veledimex - arm 1	Alaunos Therapeutics, Inc. (TCRT)
oral veledimex - arm 2	Alaunos Therapeutics, Inc. (TCRT)

Phase 1(3)

Drug	Company
mb-101	Fortress Biotech Inc. (FBIO)
mb-101	Fortress Biotech Inc. (FBIO)
Zotiraciclib	Black Diamond Therapeutics, Inc. (BDTX)

BioSniper tracks 12 drugs in development for Brain Tumor across 6 companies.

There are 9 clinical trials targeting Brain Tumor tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.